Data compiled by Redley Lamar · ChainSifter Intelligence
5Suppliers
8Customers
2Debt Items
20Related Chains
Source-Backed Evidence Depth
Clearmind Medicine Inc. (CMND) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
18Total relationships
2Distinct source URLs
5High confidence
0.745Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Reciprocal relationship from AZ graph: on to patents, we also possess other intellectual property, including trademarks, know-how, trade secrets, design rights and copyrights. We control access to an…
Reciprocal relationship from IMCC graph: KeepZone AI Inc., a position he has held since 2025, brings over 15 years of executive experience in the homeland security technology sector, with a proven tr…
Reciprocal relationship from MTEK graph: Reciprocal relationship from CMND graph: Reciprocal relationship from MTEK graph: Reciprocal relationship from CMND graph: Reciprocal relationship from MTEK g…
Reciprocal relationship from PLRZ graph: beling or product candidates insert requirements of the FDA or other regulatory authorities, including any limitations or warnings contained in a product cand…
Reciprocal relationship from SPRC graph: NOTE 7:- INVESTMENT IN ASSOCIATES MitoCareX Transaction On March 10, 2022, the Company entered into a Founders and Investment Agreement with Dr. Alon Silberma…
Reciprocal relationship from SPRC graph: Reciprocal relationship from CMND graph: and regulations such as privacy regulations, tax laws, export and import restrictions, employment laws, regulatory re…
and regulations such as privacy regulations, tax laws, export and import restrictions, employment laws, regulatory requirements and other governmental approvals, permits, and licenses; ● failure by u…
AEGIS-CAPITAL-CORP
AEGIS-CAPITAL-CORP
62%
. (xiv) During the period between September 5, 2024 and September 19, 2024, 22,500 common shares were issued in respect of RSU’s that had been fully vested. The RSU’s had a fair value of $ 30,645 at …
AWAKN-LIFE-SCIENCES-B-MORE-INC
AWAKN-LIFE-SCIENCES-B-MORE-INC
62%
cluding price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourag…
CYNTAR-VENTURES-INC
CYNTAR-VENTURES-INC
62%
d result in large fines and penalties; and ● tax disputes with foreign taxing authorities, and any resultant taxation in foreign jurisdictions associated with operations in such jurisdictions, includ…
DEVELOPMENT-COMPANY-LTD
DEVELOPMENT-COMPANY-LTD
62%
or permanent closure of a facility. Any such remedial measures imposed upon us or third parties with whom we contract could materially harm our business. Additionally, if supply from one approved man…
JOURNEY-COLAB-CORP
JOURNEY-COLAB-CORP
62%
cluding price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourag…
YISSUM-RESEARCH-DEVELOPMENT-COMPANY
YISSUM-RESEARCH-DEVELOPMENT-COMPANY
62%
or permanent closure of a facility. Any such remedial measures imposed upon us or third parties with whom we contract could materially harm our business. Additionally, if supply from one approved man…
Clearmind Medicine Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
CMND-DEBT-8720
Warrants outstanding: 60
90%
xbrl warrant detail from xbrl 2023-04-30.
CMND-DEBT
Debt stack $7,977
90%
Market cache reports total debt of $7,977.
Clearmind Medicine Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Clearmind Medicine Inc..
Clearmind Medicine Inc. Ownership
Holder
Name
Confidence
Evidence
CMND-OWNER-JPMORGAN-CHASE-CO
JPMORGAN CHASE & CO
95%
13F/ownership overlay lists JPMORGAN CHASE & CO; shares held 5; value $6; as of 2025-12-31.
CMND-OWNER-ADVISORSHARES-INVESTMENTS-LLC
AdvisorShares Investments, LLC
95%
13F/ownership overlay lists AdvisorShares Investments, LLC; shares held 6,632; ownership 4.20%; value $8,421; as of 2025-12-31.
CMND-OWNER-ROYAL-BANK-OF-CANADA
Royal Bank of Canada
95%
13F/ownership overlay lists Royal Bank of Canada; shares held 14; ownership 0.01%; value $17; as of 2025-12-31.
Clearmind Medicine Inc. Extended Supply Chain Network
